Nicole DeFeudis
Editor and Reporter at Endpoints News
Biopharma reporter @endpts | [email protected]
Articles
-
1 week ago |
endpts.com | Nicole DeFeudis
The UK on Thursday authorized GSK’s Blenrep to treat certain multiple myeloma patients in two different regimens, marking the drug’s first approval worldwide since it …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Leqembi wins EU authorization for some Alzheimer's patients, giving Biogen, Eisai a boost over Lilly
1 week ago |
endpts.com | Nicole DeFeudis
European regulators on Tuesday authorized the use of Biogen and Eisai’s Alzheimer’s treatment Leqembi for some early-stage patients “under strict conditions.” The decision from the … Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
-
1 week ago |
endpts.com | Nicole DeFeudis
AbbVie and Sandoz have resolved their patent dispute over AbbVie’s blockbuster immunology drug Rinvoq. Sandoz admitted the Rinvoq patents asserted against it are “enforceable, valid … Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
-
1 week ago |
endpts.com | Nicole DeFeudis
The government is fighting in court for a plan to cut spending on overhead research costs for grantees. Primate centers fear it could cripple their …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
-
1 week ago |
endpts.com | Nicole DeFeudis
Welcome back to Endpoints Weekly! This week’s recap kicks off with Andrew Dunn’s examination of the biotech playbook for surviving market turmoil. As former Alnylam …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 2K
- Tweets
- 1K
- DMs Open
- No
The second round of Medicare price negotiations is now underway for all 15 selected drugs with signed agreements in place from the manufacturers of those drugs. https://t.co/n9ymYHNpZr
The Trump administration defended HHS’ rejection of drugmakers’ 340B rebate models “at this time." But when it comes to the companies’ proposed models, the agency specified that it “never said never.” https://t.co/ALEuGXFU8x
“I do believe that any child who dies of a vaccine-preventable illness is a tragedy in the modern era,” FDA nominee Marty Makary said during a Senate hearing today. Read more here: https://t.co/QhPX10dIT6